NUREXONE BIOLOGIC INC. Net Asset Momentum
NUREXONE BIOLOGIC INC. net asset momentum. NUREXONE BIOLOGIC INC. (J90) recorded a net asset momentum of 56.6% as of December 2025, with net assets of €2.76 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore J90 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of NUREXONE BIOLOGIC INC. (2021–2025)
Net asset momentum of NUREXONE BIOLOGIC INC. from 2021 to 2025. This chart tracks NUREXONE BIOLOGIC INC.'s year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +56.6%, with net assets of €2.76 Million EUR as of December 2025. See NUREXONE BIOLOGIC INC. net assets for net asset value and shareholders' equity analysis.
NUREXONE BIOLOGIC INC. Net Asset Momentum by Year (2021–2025)
NUREXONE BIOLOGIC INC. net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for NUREXONE BIOLOGIC INC. from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of NUREXONE BIOLOGIC INC..
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €2.76 Million | €4.08 Million | €1.32 Million | ▲ +56.6% |
| 2024 | €1.76 Million | €2.44 Million | €680.00K | ▲ +831.7% |
| 2023 | €189.00K | €2.17 Million | €1.98 Million | ▼ -91.0% |
| 2022 | €2.10 Million | €2.79 Million | €698.00K | ▲ +78.1% |
| 2021 | €1.18 Million | €2.84 Million | €1.66 Million | — |